572 related articles for article (PubMed ID: 33601307)
21. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
[TBL] [Abstract][Full Text] [Related]
22. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.
Vasylyeva TI; Smyrnov P; Strathdee S; Friedman SR
J Int AIDS Soc; 2020 Jul; 23(7):e25583. PubMed ID: 32697423
[TBL] [Abstract][Full Text] [Related]
23. Impacts of COVID-19 on sexual risk behaviors, safe injection practices, and access to HIV services among key populations in Zambia: Findings from a rapid qualitative formative assessment.
Parmley LE; Nkumbula T; Chilukutu L; Chelu L; Mulemfwe C; Hanunka B; Mwale J; Neal J; Handema R; Kasonde P; Mutale K; Sakala HM; Lahuerta M
PLoS One; 2023; 18(8):e0289007. PubMed ID: 37527283
[TBL] [Abstract][Full Text] [Related]
24. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
25. Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?
Njoroge J; Hope VD; O'Halloran C; Edmundson C; Glass R; Parry JV; Ncube F
Epidemiol Infect; 2019 Jan; 147():e244. PubMed ID: 31364574
[TBL] [Abstract][Full Text] [Related]
26. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.
Glass R; Hope VD; Njoroge J; Edmundson C; Smith J; McVeigh J; Parry J; Desai M
Drug Alcohol Depend; 2019 Feb; 195():40-44. PubMed ID: 30580202
[TBL] [Abstract][Full Text] [Related]
27. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
May T; Dawes J; Fancourt D; Burton A
Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
[TBL] [Abstract][Full Text] [Related]
28. The characteristics of people who inject drugs in the United Kingdom: changes in age, duration, and incidence of injecting, 1980-2019, using evidence from repeated cross-sectional surveys.
Lewer D; Croxford S; Desai M; Emanuel E; Hope VD; McAuley A; Phipps E; Tweed EJ
Addiction; 2022 Sep; 117(9):2471-2480. PubMed ID: 35546310
[TBL] [Abstract][Full Text] [Related]
29. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
[TBL] [Abstract][Full Text] [Related]
30. Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women?
Marongiu A; Hope VD; Parry JV; Ncube F
Sex Transm Infect; 2012 Oct; 88(6):456-61. PubMed ID: 22628667
[TBL] [Abstract][Full Text] [Related]
31. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
32. The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services.
Aponte-Melendez Y; Mateu-Gelabert P; Fong C; Eckhardt B; Kapadia S; Marks K
Harm Reduct J; 2021 Nov; 18(1):118. PubMed ID: 34819070
[TBL] [Abstract][Full Text] [Related]
33. A cross-sectional study of factors associated with COVID-19 testing among people who inject drugs: missed opportunities for reaching those most at risk.
Yeager S; Abramovitz D; Harvey-Vera AY; Vera CF; Algarin AB; Smith LR; Rangel G; Artamonova I; Patterson TL; Bazzi AR; Brugman EL; Strathdee SA
BMC Public Health; 2022 Apr; 22(1):842. PubMed ID: 35473678
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
[TBL] [Abstract][Full Text] [Related]
35. The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual.
Gilchrist G; Swan D; Shaw A; Keding A; Towers S; Craine N; Munro A; Hughes E; Parrott S; Strang J; Taylor A; Watson J
Harm Reduct J; 2017 Mar; 14(1):14. PubMed ID: 28320406
[TBL] [Abstract][Full Text] [Related]
36. Exploration of the unmet health care needs of people who inject drugs.
Dion K; Chiodo L; Whynott L; Loftus B; Alvarez P; Shanahan J; Quaglia G; Roman A; Sorbi E; Wilkins-Carmody D
J Am Assoc Nurse Pract; 2020 Jan; 32(1):60-69. PubMed ID: 30951007
[TBL] [Abstract][Full Text] [Related]
37. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
38. "Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam".
Giang HT; Duc NQ; Molès JP; Vinh VH; Nagot N; Thanh NTT; Huong DT; Oanh KTH; Khue PM; Mai LS; Trang NT; Ngoc PT; Quillet C; Feelemyer J; Vallo R; Michel L; Jarlais DD; Laureillard D; Rapoud D
Int J Drug Policy; 2022 Dec; 110():103870. PubMed ID: 36244242
[TBL] [Abstract][Full Text] [Related]
39. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
Baluku M; Wamala T; Muhangi D
Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
[TBL] [Abstract][Full Text] [Related]
40. Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15.
Hope VD; McVeigh J; Smith J; Glass R; Njoroge J; Tanner C; Parry JV; Ncube F; Desai M
Drug Alcohol Depend; 2017 Oct; 179():83-86. PubMed ID: 28759821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
